About OncoRes Medical
OncoRes Medical is a company based in Nedlands (Australia) founded in 2014.. OncoRes Medical has raised $33.15 million across 5 funding rounds from investors including Australian Unity, MTPConnect and business.gov.au. OncoRes Medical offers products and services including Intraoperative Imaging System. OncoRes Medical operates in a competitive market with competitors including SpectraWAVE, NinePoint Medical, MedLumics, ZAP-X and DAMAE Medical, among others.
- Headquarter Nedlands, Australia
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Oncores Medical Pty Ltd
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$33.15 M (USD)
in 5 rounds
-
Latest Funding Round
$19.21 M (USD), Series B
Feb 12, 2026
-
Investors
Australian Unity
& 4 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of OncoRes Medical
OncoRes Medical offers a comprehensive portfolio of products and services, including Intraoperative Imaging System. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Provides real-time tissue microstructure assessment using OCT and elastography during surgery.
Unlock access to complete
Unlock access to complete
Unlock access to complete
Funding Insights of OncoRes Medical
OncoRes Medical has successfully raised a total of $33.15M across 5 strategic funding rounds. The most recent funding activity was a Series B round of $19.21 million completed in February 2026. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 5
- Last Round Series B — $19.2M
-
First Round
First Round
(02 Jun 2017)
- Investors Count 5
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb, 2026 | Amount | Series B - OncoRes Medical | Valuation |
investors |
|
| Oct, 2022 | Amount | Grant - OncoRes Medical | Valuation |
investors |
|
| May, 2022 | Amount | Grant - OncoRes Medical | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in OncoRes Medical
OncoRes Medical has secured backing from 5 investors, including institutional and venture fund investors. Prominent investors backing the company include Australian Unity, MTPConnect and business.gov.au. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Brandon BioCatalyst is recognized as the largest life science investment fund in Australia and New Zealand, focused on transforming biomedical research into medical products.
|
Founded Year | Domain | Location | |
|
Seed & Early stage Life-Sciences focused VC Firm investing primarily in Australia
|
Founded Year | Domain | Location | |
|
Australia's life sciences innovation is accelerated by MTPConnect.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by OncoRes Medical
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - OncoRes Medical
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Oncores Medical Comparisons
Competitors of OncoRes Medical
OncoRes Medical operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as SpectraWAVE, NinePoint Medical, MedLumics, ZAP-X and DAMAE Medical, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Photonic imaging diagnostics for cardiovascular disease treatment are provided.
|
|
| domain | founded_year | HQ Location |
Optical coherence tomography systems for tissue microstructure imaging are developed.
|
|
| domain | founded_year | HQ Location |
Biological tissue imaging is developed using optical coherence tomography.
|
|
| domain | founded_year | HQ Location |
Developer of gyroscopic radiosurgery platform
|
|
| domain | founded_year | HQ Location |
Non-invasive 3D imaging devices for skin cancer diagnostics are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Oncores Medical
Frequently Asked Questions about OncoRes Medical
When was OncoRes Medical founded?
OncoRes Medical was founded in 2014 and raised its 1st funding round 3 years after it was founded.
Where is OncoRes Medical located?
OncoRes Medical is headquartered in Nedlands, Australia. It is registered at Nedlands, Western Australia, Australia.
Is OncoRes Medical a funded company?
OncoRes Medical is a funded company, having raised a total of $33.15M across 5 funding rounds to date. The company's 1st funding round was a Grant of $3M, raised on Jun 02, 2017.
What does OncoRes Medical do?
OncoRes Medical was founded in 2014 in Nedlands, Australia, within the medical technology sector. Intraoperative imaging systems are developed by the company, integrating optical coherence tomography and elastography for real-time tissue assessment at microscopic scales. Operations center on probes that assist breast cancer surgeons in detecting residual tumors post-excision, aiming to lower reoperation rates through enhanced procedural accuracy.
Who are the top competitors of OncoRes Medical?
OncoRes Medical's top competitors include NinePoint Medical, SpectraWAVE and MedLumics.
What products or services does OncoRes Medical offer?
OncoRes Medical offers Intraoperative Imaging System.
Who are OncoRes Medical's investors?
OncoRes Medical has 5 investors. Key investors include Australian Unity, MTPConnect, business.gov.au, Brandon BioCatalyst, and Medical Research Commercialisation Fund.